Lisata Therapeutics, Inc.LSTANASDAQ
Loading
Operating Income Growth AcceleratingAccelerating
Percentile Rank92
3Y CAGR-28.5%
Year-over-Year Change
Year-over-year operating income growth rate
3Y CAGR
-28.5%/yr
vs +135.3%/yr prior
Acceleration
-163.8pp
Decelerating
Percentile
P92
Near historical high
vs 3Y Ago
0.4x
Contraction
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 30.22% |
| Q3 2025 | 9.33% |
| Q2 2025 | 16.74% |
| Q1 2025 | -18.15% |
| Q4 2024 | 7.25% |
| Q3 2024 | 3.39% |
| Q2 2024 | 16.33% |
| Q1 2024 | -9.56% |
| Q4 2023 | -1.02% |
| Q3 2023 | 13.25% |
| Q2 2023 | -0.45% |
| Q1 2023 | -4.65% |
| Q4 2022 | 82.66% |
| Q3 2022 | -461.31% |
| Q2 2022 | -1.51% |
| Q1 2022 | 3.34% |
| Q4 2021 | 1.71% |
| Q3 2021 | 2.50% |
| Q2 2021 | 11.61% |
| Q1 2021 | -48.48% |
| Q4 2020 | -1.79% |
| Q3 2020 | -24.65% |
| Q2 2020 | -5.79% |
| Q1 2020 | 20.17% |
| Q4 2019 | -0.20% |
| Q3 2019 | 5.13% |
| Q2 2019 | -16.42% |
| Q1 2019 | -20.97% |
| Q4 2018 | -0.88% |
| Q3 2018 | 11.85% |
| Q2 2018 | 17.25% |
| Q1 2018 | 29.52% |
| Q4 2017 | -19.41% |
| Q3 2017 | 20.49% |
| Q2 2017 | -19.85% |
| Q1 2017 | -8.72% |
| Q4 2016 | -3.30% |
| Q3 2016 | 22.66% |
| Q2 2016 | 33.12% |
| Q1 2016 | 81.46% |